Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
14.26
+0.22 (1.57%)
Oct 17, 2025, 4:00 PM EDT - Market closed

Theravance Biopharma Market Cap

Theravance Biopharma has a market cap or net worth of $718.15 million as of October 17, 2025. Its market cap has increased by 78.78% in one year.

Market Cap
718.15M
Enterprise Value
425.81M
1-Year Change
78.78%
Ranking
Category
Stock Price
$14.26

Market Cap Chart

Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $718.15M, a decrease of -3.04%. That is a compound annual growth rate of -0.27%.

History

DateMarket Cap% Change
Oct 17, 2025718.20M55.22%
Dec 31, 2024462.70M-17.33%
Dec 29, 2023559.70M-25.95%
Dec 30, 2022755.80M-7.20%
Dec 31, 2021814.40M-28.37%
Dec 31, 20201.14B-22.64%
Dec 31, 20191.47B3.64%
Dec 31, 20181.42B-6.02%
Dec 29, 20171.51B-8.88%
Dec 30, 20161.66B166.99%
Dec 31, 2015620.20M28.99%
Dec 31, 2014480.80M-35.09%
May 16, 2014740.70M-
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition